SCHEMBL25501940

SCHEMBL25501940

COc1c(Nc2ccc(C)cc2)c(=O)c1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.50
CYP2C9 P11712 1/20 0.50
MAPT P10636 2/20 0.47
POLB P06746 3/20 0.46
HPGD P15428 2/20 0.46
NPC1 O15118 2/20 0.46
ALDH1A1 P00352 2/20 0.46
RAB9A P51151 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
KDM4E B2RXH2 1/20 0.46
LMNA P02545 1/20 0.46
GLA P06280 1/20 0.46
MAPK1 P28482 1/20 0.46
HTT P42858 1/20 0.46
RECQL P46063 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
RAPGEF4 Q8WZA2 1/20 0.46
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
CHEK1 O14757 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2773108 0.85 MAPT (0.57) MAPTPOLBHPGDNPC1ALDH1A1
SCHEMBL2772692 0.84 POLB (0.49) MAPTPOLBNPC1RAB9ALMNA
SCHEMBL2994041 0.84 POLB (0.45) CYP1A2CYP2C9MAPTPOLBHPGD
SCHEMBL2775099 0.84 POLB (0.45) CYP1A2CYP2C9MAPTPOLBHPGD
SCHEMBL2770446 0.84 POLB (0.47) CYP1A2CYP2C9MAPTPOLBHPGD
SCHEMBL2993822 0.83 POLB (0.51) MAPTPOLBHPGDALDH1A1SMN1; SMN2
SCHEMBL30115034 0.81 POLB (0.47) MAPTPOLBNPC1ALDH1A1RAB9A
SCHEMBL2773341 0.81 BCL9 (0.46) MAPTPOLBMAPK1MEN1KMT2A
SCHEMBL7916278 0.81 POLB (0.70) CYP1A2CYP2C9MAPTPOLBNPC1
SCHEMBL2773336 0.80 POLB (0.46) MAPTPOLBMAPK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230146127-A1 3-DIARYLMETHYLENES AND USES THEREOF ATUX ISKAY LLC 2023-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230146127-A1 3-DIARYLMETHYLENES AND USES THEREOF MYC, MYCBP, FOXO1 CYP1A2 4063/4885CYP2C9 4652/4885MAPT 2576/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.